Patient Guide: A 52-Week, Multicenter, Randomized, Double-blind, Placebo and Active-Controlled, Operationally Seamless Phase 2b/3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease (INTREPID Lead-In)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 90 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03759288
Status: STOPPED
Condition: Crohn's Disease, IBD
Phase: Phase II, Phase III

Find a Study Location Near You

This study is available at 90 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Phoenix, Arizona
  • Little Rock, Arkansas
  • Lancaster, California
  • • And 87 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily